Corriente Advisors as of March 31, 2021
Portfolio Holdings for Corriente Advisors
Corriente Advisors holds 10 positions in its portfolio as reported in the March 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Maxar Technologies | 36.9 | $100M | 2.7M | 37.82 | |
| Replimune Group (REPL) | 12.1 | $33M | 1.1M | 30.51 | |
| Cue Biopharma (CUE) | 11.5 | $31M | 2.5M | 12.20 | |
| Cardiff Oncology (CRDF) | 9.5 | $26M | 2.8M | 9.26 | |
| Teledyne Technologies Incorporated (TDY) | 8.4 | $23M | 55k | 413.65 | |
| Tff Pharmaceuticals | 7.8 | $21M | 1.6M | 13.57 | |
| Facebook Cl A (META) | 5.4 | $15M | 50k | 294.54 | |
| Lantern Pharma (LTRN) | 4.8 | $13M | 714k | 18.14 | |
| Diamedica Therapeutics Com New (DMAC) | 2.9 | $8.0M | 870k | 9.15 | |
| Eyepoint Pharmaceuticals Com New (EYPT) | 0.7 | $2.0M | 200k | 10.16 |
